No abstract available
Plain language summary
This economic evaluation assesses potential Medicare Part D savings on ophthalmic generic drugs if discount coupon prices are used.
MeSH terms
-
Cost Savings
-
Drug Costs*
-
Drugs, Generic* / economics
-
Humans
-
Medicare Part D* / economics
-
Ophthalmic Solutions
-
United States
Substances
-
Drugs, Generic
-
Ophthalmic Solutions